▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Cerus (NASDAQ: CERS)

$1.34

(3.9%)

$0.05

Price as of May 16, 2025, 3:58 p.m. ET

Cerus Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
CERS	-32.14%	-74.62%	-23.96%	-89%
S&P	+12.48%	+108.07%	+15.76%	+658%

Cerus Company Info

Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

News & Analysis

Featured Article

Here's Why Cerus Corporation Stock Popped Today

Preliminary third-quarter results pleased the crowd at the company's annual investor meeting.

Cory Renauer | Oct 16, 2018

Featured Article

Here's Why Cerus Corporation Stock Is Surging Today

A better-than-expected outlook after the company's first-quarter report is lifting more than spirits.

Cory Renauer | May 9, 2018

Here's Why Cerus Corporation Stock Popped Today

Cory Renauer | Jan 24, 2018

Positive pivotal trial results bode well for the company's new blood transfusion product.

Here's Why Cerus Corporation Rose as Much as 23.6% Today

Maxx Chatsko | Nov 3, 2017

The biopharma reported third-quarter 2017 results and additional business updates.

Why Cerus Corporation Stock Marched Higher Today

George Budwell | Oct 5, 2017

A positive regulatory development sent Cerus' shares higher today.

Here's Why Cerus Corporation Rose as Much as 17.4% Today

Maxx Chatsko | Jun 7, 2017

The company provided an update on the most pressing issue facing the biopharma stock in 2017.

Here's Why Cerus Corporation Rose as Much as 16.3% Today

Maxx Chatsko | May 26, 2017

Even with today's pop, the stock is near six-year lows.

Here's Why Cerus Corporation Stock Is Tanking Today

Brian Feroldi | May 23, 2017

Investors headed for the exits after the company announced an unexpected product supply shortage.

Valuation

Earnings Transcripts

Cerus (CERS) Q2 2022 Earnings Call Transcript

CERS earnings call for the period ending June 30, 2022.

Motley Fool Transcribing | Aug 5, 2022

Cerus (CERS) Q1 2022 Earnings Call Transcript

CERS earnings call for the period ending March 31, 2022.

Motley Fool Transcribing | May 6, 2022

Cerus (CERS) Q4 2021 Earnings Call Transcript

CERS earnings call for the period ending December 31, 2021.

Motley Fool Transcribing | Feb 22, 2022

Cerus Corporation (CERS) Q3 2021 Earnings Call Transcript

CERS earnings call for the period ending September 30, 2021.

Motley Fool Transcribers | Nov 3, 2021

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services